Rationale, Design, and Baseline Characteristics of a Trial Comparing Aggressive Lipid Lowering With Atorvastatin Versus Revascularization Treatments (AVERT) fn1fn1This work is supported by a grant from Parke-Davis Pharmaceutical Research, a Division of Warner-Lambert Company, Ann Arbor, Michigan.
Authors:
- 1 November 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (9) , 1130-1133
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Lipid Lowering Versus RevascularizationCirculation, 1997
- Is cholesterol lowering an alternative to revascularization in some patients with coronary artery disease?Archives of internal medicine (1960), 1995
- The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery interventionCardiovascular Drugs and Therapy, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Ruling out Acute Myocardial InfarctionNew England Journal of Medicine, 1991
- Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial InfarctionJAMA, 1988
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979
- Letter: Grading of angina pectoris.Circulation, 1976